cholest-5-ene-3,4-diol has been researched along with Fatty Liver, Nonalcoholic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, N; Fukiya, S; Furukawa, Y; Hagio, M; Hanai, T; Hayashi, T; Hori, S; Ishizuka, S; Iwaya, H; Joe, GH; Kikuchi, K; Lee, JY; Nose, T; Ogura, Y; Ooka, T; Sato, M; Shimizu, H; Shirouchi, B; Tada, K; Takeuchi, A; Tanaka, Y; Tsuji, M; Watanabe, M; Yokota, A; Yoshitsugu, R | 1 |
1 other study(ies) available for cholest-5-ene-3,4-diol and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
12α-Hydroxylated bile acid induces hepatic steatosis with dysbiosis in rats.
Topics: Animals; Bile Acids and Salts; Cholic Acids; Deoxycholic Acid; Dysbiosis; Hydroxycholesterols; Hydroxylation; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Taurocholic Acid | 2020 |